Delaware Federal Judge Consolidates Patent Disputes Over Proposed Generic Drugs
WILMINGTON, Del. — Opposition by Alembic Pharmaceuticals Inc. to a motion to consolidate two separate patent infringement lawsuits was unsuccessful April 12, when a Delaware federal judge instead found that “the...To view the full article, register now.
Already a subscriber? Click here to view full article